Chemomab Announces New Medical and Clinical Appointments


David M. Weiner, MD, Rejoins Chemomab as Interim Chief Medical Officer, Bringing Extensive Biotechnology and Pharmaceutical Industry R&D, Drug Development and Strategic Experience

Go here to see the original:
Chemomab Announces New Medical and Clinical Appointments

Related Posts